Apolipoprotein A-I of Hyperlipidemia Atherosclerosis Prone (LAP) Quail: Cdna Sequence and tissue expression

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 1, 1999, Pages 29-34

  Iwasaki, Hironori ^a   Oku, Hirosuke ^a   Toda, Takayoshi ^a   Nasu, Tetsuo ^a,b   Oda, Koji ^a   Miyagi, Tsuyoshi ^a   Chinen, Isao ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Apolipoprotein A I; Expression level; Mrna; Quail; Sequence

Indexed keywords

APOLIPOPROTEIN A1; COMPLEMENTARY DNA; MESSENGER RNA;

AMINO ACID SEQUENCE; ANIMAL; ARTERIOSCLEROSIS; ARTICLE; COTURNIX; GENE EXPRESSION; GENETICS; HYPERLIPIDEMIA; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; BASE SEQUENCE; COTURNIX; DNA, COMPLEMENTARY; GENE EXPRESSION; HYPERLIPIDEMIAS; MALE; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE DISTRIBUTION;

EID: 0032602983     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.29     Document Type: Article

References (20)

1. Oku, H., Toda, T., Nagata, J., Ishikawa, M., Neyazaki, K., Shinjo, C., and Chinen, I., Apolipoprotein A-l of Japanese quail: cDNA sequence and modulation of tissue expression by cholesterol feeding. Biosci. Biotechnol. Biochem., 61, 286-290 (1997).
2. Inoue, Y., Toda, T., Igawa, T., Tani, T., and Kimura, Y., The response of serum and hepatic lipids and the aortic wall to different levels of dietary cholesterol: a comparative study between hyperlipidemia-and-atherosclerosis-prone quail and commercially available quail. Tohoku J. Exp. Med., 175, 1-13 (1995).
3. Nagata, J., Oku, H., Toda, T., and Chinen, I., Effect of dietary cholesterol on the activities of key enzymes of cholesterol metabolism in hyperlipidemia-and atherosclerosis-prone Japanese quail. J. Nutr. Sci. Vitaminol., 42, 287-300 (1996).
4. Nagata, J., Maeda, G., Oku, H., Toda, T., and Chinen, I., Lipoprotein and apolipoprotein profiles of hyperlipidemic atherosclerosis-prone Japanese quail. J. Nutr. Sci. Vitaminol., 43, 47-57 (1997).
5. Shih, C. H., Pullman, E. P., and Kao, K. J., Genetic selection, general characterization, and histology of atherosclerosis-susceptible and -resistant Japanese quail. Atherosclerosis, 49, 41-53 (1983).
6. Chapman, M. J., Animal Lipoproteins: Chemistry, structure, and comparative aspects. J. Lipid Res., 21, 789-853 (1980).
7. Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., and Hennekens, C. H., A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med., 325, 373-381 (1991).
8. Glomset, J. A., The plasma lecithin: cholesterol acyltransferase reaction. J. Lipid Res., 9, 155-167 (1968).
9. Hara, H., Yokoyama, S., Role of apolipoprotein in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-β high-density lipoprotein pathway. Biochem., 31, 2040-2046 (1992).
10. Gordon, D. J., and Rifkind, B. M., High-density lipoproteins— the clinical implications of recent studies. N. Engl. J. Med., 321, 1311-1316 (1989).
11. Badimon, J. J., Badimon, L., and Fuster, V., Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J. Clin. Invest., 85, 1234-1241 (1990).
12. Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y., Naito, M., Ruan, Y., Takahashi, K., Ohta, T., and Horiuchi, S., Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Atherioscler. Thromb. Vase. Biol., 15, 1882-1888 (1995).
13. Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., and Clift, S. M., Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature, 353, 265-267 (1991).
14. Deeb, S. S., Cheung, M. C., Peng, R., Wolf, A. C., Stern, R., Albers, J. J., and Knopp, R. H., A mutation in the human apolipoprotein A-I gene. J. Biol. Chem., 266, 13654-13660 (1991).
15. Karathansis, S. K., Ferris, E., and Haddad, I. A., DNA inversion within the apolipoprotein AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc. Natl. Acad. Sci. USA, 84, 7198-7202 (1987).
16. Oku, H., Ishikawa, M., Nagata, J., Toda, T., and Chinen, I., Lipoprotein and apoprotein profile of Japanese quail. Biochim. Biophys. Acta., 1167, 22-28 (1993).
17. Snedecor, G. W., and Cochran, W. G., Two-way tables with unequal numbers and proportions. In “STATISTICAL METHODS” 7 th ed., ed. by The Iowa State University Press, Ames, Iowa, U.S.A., pp. 414-433 (1980).
18. Ferrari, S., Tarugi, P., Drusiani, E., Calandra, S., and Fregni, M., The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick. Gene, 60, 39-46 (1987).
19. Li, H., Reddick, R. L., and Maeda, N., Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb., 13, 1814-1821 (1993).
20. Schultz, J. R., Verstuyft, J. G., Gong, E. L., Nichols, A. V., and Rubin, E. M., Protein composition determines the antiatherogenic properties of HDL in transgenic mice. Nature, 365, 762-764 (1993).